Skip to main content
Premium Trial:

Request an Annual Quote

Berry & Associates Wins $749K SBIR Grant to Continue Developing Oligo Purification Technology

NEW YORK, April 5 (GenomeWeb News) - Berry & Associates, a privately held Michigan chemistry company, said today that it has been awarded a $ $748,727 Small Business Innovation Research grant from the National Institute of General Medical Sciences to continue its work on oligonucleotide purification.


Berry & Associates said that the new funding complements an earlier Phase I SBIR grant to develop a method of purifying oligonucleotides based on a technique known as fluorous affinity purification.


The new funding will enable the company to extend the initial work, specifically to provide specific functionality for diagnostic and therapeutic use, according to the company.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.